First Manhattan’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-60,260
| Closed | -$47.1M | – | 1643 |
|
|
2021
Q1 | $47.1M | Sell |
60,260
-13,568
| -18% | -$10.6M | 0.2% | 65 |
|
|
2020
Q4 | $40.2M | Buy |
73,828
+14,816
| +25% | +$8.07M | 0.19% | 69 |
|
|
2020
Q3 | $27M | Buy |
59,012
+5,934
| +11% | +$2.72M | 0.14% | 85 |
|
|
2020
Q2 | $32.7M | Buy |
53,078
+13,011
| +32% | +$8.01M | 0.19% | 72 |
|
|
2020
Q1 | $19.1M | Hold |
40,067
| – | – | 0.12% | 89 |
|
|
2019
Q4 | $23.2M | Sell |
40,067
-11,772
| -23% | -$6.83M | 0.12% | 99 |
|
|
2019
Q3 | $34.1M | Sell |
51,839
-2,000
| -4% | -$1.32M | 0.19% | 82 |
|
|
2019
Q2 | $41.7M | Buy |
53,839
+26,583
| +98% | +$20.6M | 0.23% | 68 |
|
|
2019
Q1 | $19.3M | Buy |
27,256
+4,016
| +17% | +$2.84M | 0.11% | 108 |
|
|
2018
Q4 | $10.9M | Buy |
23,240
+7,768
| +50% | +$3.64M | 0.07% | 159 |
|
|
2018
Q3 | $13.3M | Hold |
15,472
| – | – | 0.07% | 158 |
|
|
2018
Q2 | $10.7M | Buy |
15,472
+10,414
| +206% | +$7.18M | 0.06% | 174 |
|
|
2018
Q1 | $2.25M | Buy |
5,058
+2,225
| +79% | +$992K | 0.01% | 343 |
|
|
2017
Q4 | $1.25M | Buy |
+2,833
| New | +$1.25M | 0.01% | 418 |
|